Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case–control study of the ALSPAC cohort

Byrne, Jonah F., Healy, Colm, Mongan, David, Susai, Subash Raj, Zammit, Stanley ORCID: https://orcid.org/0000-0002-2647-9211, Focking, Melanie, Cannon, Melanie and Cotter, David 2022. Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case–control study of the ALSPAC cohort. Translational Psychiatry 12 (1) , 377. 10.1038/s41398-022-02142-2

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (710kB) | Preview

Abstract

Individuals with psychotic disorders and depressive disorder exhibit altered concentrations of peripheral inflammatory markers. It has been suggested that clinical trials of anti-inflammatory therapies for psychiatric disorders should stratify patients by their inflammatory profile. Hence, we investigated whether different subgroups of individuals exist across psychiatric disorders, based on their inflammatory biomarker signatures. We measured the plasma concentrations of 17 inflammatory markers and receptors in 380 participants with psychotic disorder, depressive disorder or generalised anxiety disorder and 399 controls without psychiatric symptoms from the ALSPAC cohort at age 24. We employed a semi-supervised clustering algorithm, which discriminates multiple clusters of psychiatric disorder cases from controls. The best fit was for a two-cluster model of participants with psychiatric disorders (Adjusted Rand Index (ARI) = 0.52 ± 0.01) based on the inflammatory markers. Permutation analysis indicated the stability of the clustering solution performed better than chance (ARI = 0.43 ± 0.11; p < 0.001), and the clusters explained the inflammatory marker data better than a Gaussian distribution (p = 0.021). Cluster 2 exhibited marked increases in sTNFR1/2, suPAR, sCD93 and sIL-2RA, compared to cluster 1. Participants in the cluster exhibiting higher inflammation were less likely to be in employment, education or training, indicating poorer role functioning. This study found evidence for a novel pattern of inflammatory markers specific to psychiatric disorders and strongly associated with a transdiagnostic measure of illness severity. sTNFR1/2, suPAR, sCD93 and sIL-2RA could be used to stratify clinical trials of anti-inflammatory therapies for psychiatric disorders.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	Springer Nature [academic journals on nature.com]
ISSN:	2158-3188
Date of First Compliant Deposit:	16 August 2022
Date of Acceptance:	25 August 2022
Last Modified:	23 May 2023 15:44
URI:	https://orca.cardiff.ac.uk/id/eprint/151976

Actions (repository staff only)

Edit Item